Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review

KH Mayer, A Agwu, D Malebranche - Advances in therapy, 2020 - Springer
Antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV transmission was first
approved by the US Food and Drug Administration in 2012. Despite correlations of …

Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel

RT Gandhi, R Bedimo, JF Hoy, RJ Landovitz, DM Smith… - Jama, 2023 - jamanetwork.com
Importance Recent advances in treatment and prevention of HIV warrant updated
recommendations to guide optimal practice. Objective Based on a critical evaluation of new …

[HTML][HTML] HIV preexposure prophylaxis and treatment as prevention—beliefs and access barriers in men who have sex with men (MSM) and transgender women: a …

JJ Matacotta, FJ Rosales-Perez… - Journal of Patient …, 2020 - ncbi.nlm.nih.gov
Purpose While the annual rate of new HIV infections and diagnoses has remained stable for
most groups, troubling increases are seen in transgender women and racial/ethnic-minority …

Characterization of HIV preexposure prophylaxis use behaviors and HIV incidence among US adults in an integrated health care system

JC Hojilla, LB Hurley, JL Marcus… - JAMA network …, 2021 - jamanetwork.com
Importance Long-term follow-up is needed to evaluate gaps in HIV preexposure prophylaxis
(PrEP) care delivery and to identify individuals at risk for falling out of care. Objective To …

Facilitators and barriers of pre-exposure prophylaxis (PrEP) uptake among rural men who have sex with men living in the Midwestern US

C Owens, RD Hubach, D Williams, E Voorheis… - Archives of sexual …, 2020 - Springer
Facilitators and barriers of Pre-exposure Prophylaxis (PrEP) uptake have been established
in prior studies; however, most of these studies comprise samples of MSM from metropolitan …

Update on HIV preexposure prophylaxis: effectiveness, drug resistance, and risk compensation

VE Powell, KM Gibas, J DuBow… - Current infectious disease …, 2019 - Springer
Abstract Purpose of Review In 2019, the US government launched an initiative to decrease
new HIV infections by 90% over the next decade. Studies have demonstrated the efficacy of …

Patient-led decision-making for HIV preexposure prophylaxis

WC Sewell, P Solleveld, D Seidman… - Current HIV/AIDS …, 2021 - Springer
Abstract Purpose of Review Shared decision-making is a process that involves bidirectional
exchange of information between patients and providers to support patients in making …

The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs

SM Walters, B Coston, A Neaigus, AV Rivera… - International Journal of …, 2020 - Elsevier
Background Male persons who inject drugs (male PWID) are at heightened risk for HIV,
particularly if they also have sex with men. Pre-exposure prophylaxis (PrEP) could aid in HIV …

Health care coverage and preexposure prophylaxis (PrEP) use among men who have sex with men living in 22 US cities with vs without Medicaid expansion, 2017

AR Baugher, T Finlayson, R Lewis… - … journal of public …, 2021 - ajph.aphapublications.org
Objectives. To compare health care coverage and utilization between men who have sex
with men (MSM) in Medicaid expansion versus nonexpansion states. Methods. We used …

Estimated Uncovered Costs For HIV Preexposure Prophylaxis In The US, 2018: Study examines the uncovered costs for HIV Pre-exposure prophylaxis in the US in …

RA Bonacci, M Van Handel, R Huggins, S Inusah… - Health …, 2023 - healthaffairs.org
The cost of HIV preexposure prophylaxis (PrEP) medication and care is a key barrier to PrEP
use. Using population-based surveys and published information, we estimated the number …